Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

Medicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published in JAMA, demonstrate how state coverage decisions can have an immediate and substantial effect on access to these medications.

Read original article on Medical Xpress - latest medical and health news stories →